Skip to content

Curanex Pharmaceuticals Inc

CURX

CIK 0002025942

← back to feed
Revenue (TTM)
—
Q1 May 2026
Net Income (TTM)
−$4.3M
−1,068.8% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.16
−466.7% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
—
Q1 May 2026
Net Margin
—
Q1 May 2026
Free Cash Flow (TTM)
—
Q1 May 2026
Cash
$4M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
28.36M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings